Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Central Nervous System Diseases | 5 | 2016 | 520 | 1.200 |
Why?
|
Spinal Cord | 6 | 2017 | 1812 | 0.870 |
Why?
|
Subacute Combined Degeneration | 1 | 2022 | 2 | 0.840 |
Why?
|
Sodium Channels | 8 | 2008 | 341 | 0.790 |
Why?
|
Nitrous Oxide | 1 | 2022 | 166 | 0.770 |
Why?
|
CADASIL | 1 | 2022 | 83 | 0.760 |
Why?
|
Neurology | 2 | 2021 | 786 | 0.720 |
Why?
|
Intracranial Thrombosis | 1 | 2021 | 107 | 0.700 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2021 | 110 | 0.690 |
Why?
|
Brain Infarction | 2 | 2014 | 286 | 0.660 |
Why?
|
Radiation Injuries | 2 | 2017 | 1198 | 0.650 |
Why?
|
Stroke | 8 | 2022 | 9755 | 0.640 |
Why?
|
Nervous System Diseases | 4 | 2022 | 1662 | 0.620 |
Why?
|
Spinal Cord Diseases | 2 | 2022 | 291 | 0.610 |
Why?
|
Cranial Nerves | 2 | 2020 | 97 | 0.570 |
Why?
|
Anesthetics, Inhalation | 1 | 2022 | 573 | 0.570 |
Why?
|
Giant Cell Arteritis | 1 | 2021 | 307 | 0.560 |
Why?
|
Paraneoplastic Cerebellar Degeneration | 1 | 2016 | 13 | 0.550 |
Why?
|
Brain Diseases | 2 | 2017 | 1554 | 0.530 |
Why?
|
Magnetic Resonance Imaging | 26 | 2022 | 36741 | 0.520 |
Why?
|
Cerebral Veins | 2 | 2014 | 157 | 0.500 |
Why?
|
Myelitis | 1 | 2016 | 49 | 0.500 |
Why?
|
Intracranial Hypertension | 1 | 2017 | 191 | 0.490 |
Why?
|
Hypesthesia | 1 | 2016 | 106 | 0.490 |
Why?
|
Brain Stem | 3 | 2017 | 859 | 0.470 |
Why?
|
Leukoencephalopathies | 1 | 2017 | 259 | 0.470 |
Why?
|
Agraphia | 1 | 2014 | 8 | 0.470 |
Why?
|
Copper | 1 | 2016 | 368 | 0.450 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2014 | 171 | 0.440 |
Why?
|
Tuberculoma, Intracranial | 1 | 2013 | 8 | 0.440 |
Why?
|
Supraoptic Nucleus | 2 | 2004 | 28 | 0.440 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2014 | 50 | 0.440 |
Why?
|
Brain Edema | 1 | 2017 | 601 | 0.430 |
Why?
|
Radiotherapy | 2 | 2017 | 1502 | 0.430 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2013 | 23 | 0.430 |
Why?
|
Encephalomyelitis | 1 | 2013 | 37 | 0.420 |
Why?
|
Adenoviridae Infections | 1 | 2013 | 96 | 0.410 |
Why?
|
Magnetic Resonance Angiography | 4 | 2021 | 1429 | 0.410 |
Why?
|
Seizures | 2 | 2017 | 2998 | 0.400 |
Why?
|
Perceptual Disorders | 1 | 2014 | 199 | 0.390 |
Why?
|
Cytosine | 1 | 2013 | 213 | 0.390 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 166 | 0.390 |
Why?
|
Hospitalists | 1 | 2015 | 298 | 0.370 |
Why?
|
Aphasia | 1 | 2013 | 193 | 0.370 |
Why?
|
Brain Abscess | 1 | 2012 | 123 | 0.370 |
Why?
|
Anesthesia | 1 | 2022 | 1596 | 0.360 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2013 | 305 | 0.350 |
Why?
|
Temporal Lobe | 2 | 2017 | 1726 | 0.340 |
Why?
|
Skull Base | 1 | 2013 | 294 | 0.340 |
Why?
|
Inpatients | 1 | 2021 | 2566 | 0.340 |
Why?
|
Epilepsy | 5 | 2017 | 3326 | 0.330 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2012 | 342 | 0.320 |
Why?
|
Hippocampus | 4 | 2017 | 3783 | 0.320 |
Why?
|
Central Nervous System Neoplasms | 1 | 2017 | 928 | 0.320 |
Why?
|
Secondary Prevention | 2 | 2020 | 1474 | 0.320 |
Why?
|
Career Choice | 1 | 2015 | 769 | 0.320 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2004 | 1124 | 0.320 |
Why?
|
Parietal Lobe | 1 | 2014 | 866 | 0.310 |
Why?
|
Pregnancy Complications | 2 | 2014 | 2973 | 0.310 |
Why?
|
Oligopeptides | 1 | 2014 | 1194 | 0.310 |
Why?
|
Brain | 13 | 2021 | 27362 | 0.310 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2013 | 519 | 0.300 |
Why?
|
Cerebrovascular Circulation | 3 | 2016 | 2725 | 0.300 |
Why?
|
Editorial Policies | 1 | 2013 | 458 | 0.300 |
Why?
|
Encephalitis | 2 | 2022 | 441 | 0.300 |
Why?
|
Epilepsy, Absence | 2 | 2007 | 50 | 0.300 |
Why?
|
Ischemia | 1 | 2017 | 1900 | 0.300 |
Why?
|
Spine | 1 | 2015 | 1140 | 0.290 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2009 | 87 | 0.290 |
Why?
|
Cerebellar Diseases | 1 | 2009 | 227 | 0.290 |
Why?
|
Nerve Tissue Proteins | 7 | 2008 | 4413 | 0.280 |
Why?
|
Brain Neoplasms | 4 | 2017 | 9118 | 0.280 |
Why?
|
Tomography, X-Ray Computed | 6 | 2021 | 20762 | 0.270 |
Why?
|
Disease Progression | 5 | 2017 | 13668 | 0.260 |
Why?
|
Encephalomyelitis, Acute Disseminated | 2 | 2017 | 68 | 0.260 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2654 | 0.260 |
Why?
|
Humans | 63 | 2022 | 768171 | 0.250 |
Why?
|
Intracranial Hemorrhages | 2 | 2019 | 809 | 0.250 |
Why?
|
Vasopressins | 2 | 2004 | 358 | 0.250 |
Why?
|
Headache Disorders, Primary | 1 | 2006 | 39 | 0.250 |
Why?
|
Diagnostic Imaging | 2 | 2017 | 3533 | 0.250 |
Why?
|
Neurocysticercosis | 2 | 2017 | 91 | 0.250 |
Why?
|
Optic Nerve | 1 | 2009 | 571 | 0.240 |
Why?
|
Neurons | 5 | 2004 | 9514 | 0.240 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2785 | 0.240 |
Why?
|
Water-Electrolyte Balance | 2 | 2004 | 326 | 0.240 |
Why?
|
Blindness | 1 | 2009 | 587 | 0.240 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13677 | 0.230 |
Why?
|
Ganglia, Spinal | 3 | 2003 | 529 | 0.230 |
Why?
|
Neurons, Afferent | 2 | 2004 | 498 | 0.230 |
Why?
|
Fatal Outcome | 4 | 2013 | 1836 | 0.230 |
Why?
|
Avian Proteins | 1 | 2004 | 77 | 0.220 |
Why?
|
Diffusion Tensor Imaging | 2 | 2013 | 2420 | 0.220 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2017 | 2815 | 0.210 |
Why?
|
Migraine Disorders | 1 | 2016 | 1713 | 0.210 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2006 | 269 | 0.210 |
Why?
|
Nervous System Malformations | 2 | 2017 | 243 | 0.210 |
Why?
|
Intracranial Aneurysm | 1 | 2013 | 1271 | 0.210 |
Why?
|
Encephalitis, Varicella Zoster | 1 | 2022 | 7 | 0.200 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 40 | 0.190 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2022 | 119 | 0.190 |
Why?
|
Putamen | 1 | 2022 | 291 | 0.180 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2003 | 716 | 0.180 |
Why?
|
Vagus Nerve | 1 | 2003 | 459 | 0.170 |
Why?
|
Nerve Degeneration | 2 | 2004 | 749 | 0.170 |
Why?
|
Eye Diseases | 1 | 2006 | 660 | 0.170 |
Why?
|
Mesencephalon | 1 | 2022 | 338 | 0.170 |
Why?
|
Peripheral Nerves | 1 | 2003 | 490 | 0.170 |
Why?
|
Antigens, Surface | 1 | 2004 | 1617 | 0.170 |
Why?
|
Herpes Zoster | 1 | 2022 | 252 | 0.160 |
Why?
|
Vitamin B 12 | 1 | 2022 | 529 | 0.160 |
Why?
|
Cranial Nerve Diseases | 1 | 2020 | 111 | 0.160 |
Why?
|
Action Potentials | 2 | 2004 | 1838 | 0.160 |
Why?
|
Up-Regulation | 4 | 2004 | 4149 | 0.160 |
Why?
|
Multiple Sclerosis | 2 | 2011 | 3250 | 0.160 |
Why?
|
Blood Proteins | 1 | 2004 | 1191 | 0.150 |
Why?
|
Brain Stem Hemorrhage, Traumatic | 1 | 2017 | 13 | 0.150 |
Why?
|
Diffuse Axonal Injury | 1 | 2017 | 49 | 0.140 |
Why?
|
Cerebral Infarction | 1 | 2022 | 969 | 0.140 |
Why?
|
Cerebral Cortex | 3 | 2022 | 5812 | 0.140 |
Why?
|
Electric Stimulation Therapy | 1 | 2003 | 635 | 0.140 |
Why?
|
Sclerosis | 2 | 2017 | 211 | 0.130 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5196 | 0.130 |
Why?
|
Female | 29 | 2022 | 397187 | 0.130 |
Why?
|
Antigens, Neoplasm | 1 | 2004 | 1996 | 0.130 |
Why?
|
Middle Aged | 18 | 2022 | 223487 | 0.130 |
Why?
|
Tremor | 1 | 2016 | 197 | 0.120 |
Why?
|
Male | 30 | 2022 | 364731 | 0.120 |
Why?
|
Functional Laterality | 2 | 2014 | 2264 | 0.120 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6395 | 0.120 |
Why?
|
Nimodipine | 1 | 2014 | 56 | 0.120 |
Why?
|
Meningitis, Viral | 1 | 2014 | 50 | 0.110 |
Why?
|
Heparin | 1 | 2021 | 1636 | 0.110 |
Why?
|
Piracetam | 1 | 2014 | 88 | 0.110 |
Why?
|
Anticonvulsants | 3 | 2017 | 1923 | 0.110 |
Why?
|
Coma, Post-Head Injury | 1 | 2013 | 21 | 0.110 |
Why?
|
Antigens, CD | 1 | 2004 | 4035 | 0.110 |
Why?
|
Cerebellar Ataxia | 1 | 2014 | 151 | 0.100 |
Why?
|
Nootropic Agents | 1 | 2014 | 159 | 0.100 |
Why?
|
Polyneuropathies | 1 | 2014 | 139 | 0.100 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2013 | 37 | 0.100 |
Why?
|
Vertigo | 1 | 2014 | 205 | 0.100 |
Why?
|
Prognosis | 5 | 2021 | 30009 | 0.100 |
Why?
|
Abducens Nerve Diseases | 1 | 2012 | 44 | 0.100 |
Why?
|
Propionibacterium acnes | 1 | 2012 | 59 | 0.100 |
Why?
|
Encephalitis, Viral | 1 | 2012 | 59 | 0.100 |
Why?
|
Paresthesia | 1 | 2013 | 160 | 0.100 |
Why?
|
Astrocytoma | 1 | 2016 | 774 | 0.100 |
Why?
|
Down-Regulation | 3 | 2004 | 2939 | 0.100 |
Why?
|
Animals | 18 | 2016 | 169285 | 0.100 |
Why?
|
HIV-2 | 1 | 2012 | 156 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2892 | 0.100 |
Why?
|
Pons | 1 | 2012 | 242 | 0.090 |
Why?
|
Gadolinium | 1 | 2016 | 964 | 0.090 |
Why?
|
Adult | 16 | 2022 | 223646 | 0.090 |
Why?
|
Neurologic Examination | 1 | 2014 | 914 | 0.090 |
Why?
|
Anticoagulants | 2 | 2021 | 4850 | 0.090 |
Why?
|
Space Perception | 1 | 2014 | 466 | 0.090 |
Why?
|
Herpes Simplex | 1 | 2014 | 470 | 0.090 |
Why?
|
Gait Disorders, Neurologic | 1 | 2013 | 243 | 0.090 |
Why?
|
Disease Models, Animal | 6 | 2007 | 18349 | 0.090 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2010 | 62 | 0.090 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2017 | 1024 | 0.080 |
Why?
|
Spinal Diseases | 1 | 2015 | 561 | 0.080 |
Why?
|
Vasculitis | 1 | 2014 | 525 | 0.080 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11101 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 7 | 2008 | 8142 | 0.080 |
Why?
|
Rats | 9 | 2008 | 23782 | 0.080 |
Why?
|
Atrophy | 2 | 2011 | 1646 | 0.080 |
Why?
|
CD4 Lymphocyte Count | 2 | 2012 | 2596 | 0.080 |
Why?
|
Kindling, Neurologic | 1 | 2008 | 24 | 0.080 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 2029 | 0.080 |
Why?
|
Ophthalmic Artery | 1 | 2009 | 57 | 0.080 |
Why?
|
Thrombocytosis | 1 | 2009 | 88 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2021 | 3620 | 0.080 |
Why?
|
Ethosuximide | 1 | 2007 | 9 | 0.080 |
Why?
|
Aged | 11 | 2022 | 171502 | 0.070 |
Why?
|
Apoptosis | 1 | 2004 | 9527 | 0.070 |
Why?
|
RNA, Messenger | 6 | 2008 | 12801 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2020 | 2171 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2012 | 1049 | 0.070 |
Why?
|
Meningioma | 1 | 2016 | 1220 | 0.070 |
Why?
|
Cerebral Arteries | 1 | 2010 | 488 | 0.070 |
Why?
|
Young Adult | 8 | 2022 | 60066 | 0.070 |
Why?
|
Computational Biology | 1 | 1999 | 3567 | 0.070 |
Why?
|
Meningeal Neoplasms | 1 | 2016 | 1253 | 0.070 |
Why?
|
Endovascular Procedures | 1 | 2021 | 2217 | 0.070 |
Why?
|
Arousal | 1 | 2013 | 1180 | 0.070 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2016 | 1077 | 0.070 |
Why?
|
Fundus Oculi | 1 | 2009 | 560 | 0.070 |
Why?
|
Bhutan | 2 | 2017 | 61 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 13013 | 0.070 |
Why?
|
Pregnancy | 3 | 2014 | 30255 | 0.070 |
Why?
|
Posterior Horn Cells | 2 | 2004 | 87 | 0.070 |
Why?
|
Neuralgia | 2 | 2003 | 622 | 0.070 |
Why?
|
Models, Neurological | 1 | 2014 | 1776 | 0.070 |
Why?
|
Anti-HIV Agents | 2 | 2012 | 4573 | 0.060 |
Why?
|
Viral Load | 2 | 2012 | 3396 | 0.060 |
Why?
|
Bipolar Disorder | 1 | 2003 | 5130 | 0.060 |
Why?
|
DNA | 1 | 1999 | 7213 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2010 | 942 | 0.060 |
Why?
|
Indomethacin | 1 | 2006 | 323 | 0.060 |
Why?
|
HIV Infections | 1 | 2012 | 17569 | 0.060 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2011 | 952 | 0.060 |
Why?
|
Optic Nerve Diseases | 1 | 2009 | 342 | 0.060 |
Why?
|
Critical Care | 1 | 2017 | 2715 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2003 | 5891 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 2010 | 1264 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2017 | 3800 | 0.060 |
Why?
|
Antiviral Agents | 2 | 2014 | 3072 | 0.060 |
Why?
|
Rats, Wistar | 2 | 2007 | 1890 | 0.060 |
Why?
|
Sciatic Neuropathy | 1 | 2004 | 76 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7454 | 0.060 |
Why?
|
Disease Management | 1 | 2014 | 2535 | 0.050 |
Why?
|
Contrast Media | 1 | 2016 | 5330 | 0.050 |
Why?
|
Gliosis | 1 | 2004 | 246 | 0.050 |
Why?
|
Radiation Dosage | 1 | 2011 | 1967 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 611 | 0.050 |
Why?
|
Psoas Abscess | 1 | 2002 | 11 | 0.050 |
Why?
|
Carotid Stenosis | 1 | 2010 | 859 | 0.050 |
Why?
|
Treatment Failure | 1 | 2009 | 2661 | 0.050 |
Why?
|
Nerve Growth Factor | 1 | 2003 | 156 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2022 | 81760 | 0.050 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2002 | 98 | 0.050 |
Why?
|
Cerebellum | 1 | 2009 | 1522 | 0.050 |
Why?
|
Diabetic Neuropathies | 2 | 2002 | 410 | 0.050 |
Why?
|
Nociceptors | 2 | 2003 | 460 | 0.050 |
Why?
|
Risk Factors | 3 | 2022 | 74944 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2004 | 563 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6316 | 0.050 |
Why?
|
Caspase 3 | 1 | 2004 | 730 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 65379 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2022 | 6082 | 0.050 |
Why?
|
Glioma | 1 | 2016 | 3503 | 0.050 |
Why?
|
Afferent Pathways | 1 | 2002 | 304 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15949 | 0.050 |
Why?
|
Herpesvirus 3, Human | 1 | 2022 | 159 | 0.050 |
Why?
|
Warfarin | 1 | 2009 | 1493 | 0.050 |
Why?
|
Caspases | 1 | 2004 | 882 | 0.050 |
Why?
|
Radiography | 1 | 2011 | 6986 | 0.040 |
Why?
|
Hemorrhage | 1 | 2012 | 3466 | 0.040 |
Why?
|
Equipment Failure | 1 | 2003 | 585 | 0.040 |
Why?
|
Immunohistochemistry | 5 | 2008 | 11095 | 0.040 |
Why?
|
Adolescent | 7 | 2022 | 89169 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2022 | 8759 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3390 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2017 | 59626 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39354 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2020 | 239 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2022 | 15833 | 0.040 |
Why?
|
Electroencephalography | 2 | 2022 | 6314 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2011 | 2539 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2003 | 1741 | 0.040 |
Why?
|
Disability Evaluation | 2 | 2019 | 1835 | 0.040 |
Why?
|
Hypothalamus | 1 | 2003 | 1004 | 0.040 |
Why?
|
Aspirin | 2 | 2020 | 3135 | 0.040 |
Why?
|
Neuropeptides | 1 | 2003 | 951 | 0.040 |
Why?
|
Streptococcal Infections | 1 | 2002 | 619 | 0.040 |
Why?
|
In Situ Hybridization | 3 | 2008 | 1904 | 0.040 |
Why?
|
Antibodies, Helminth | 1 | 2016 | 59 | 0.030 |
Why?
|
Antigens, Helminth | 1 | 2016 | 69 | 0.030 |
Why?
|
Taenia solium | 1 | 2016 | 28 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2003 | 973 | 0.030 |
Why?
|
Arthralgia | 1 | 2020 | 459 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2003 | 1277 | 0.030 |
Why?
|
Fetus | 1 | 2003 | 1883 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2271 | 0.030 |
Why?
|
Spinal Cord Injuries | 1 | 2003 | 928 | 0.030 |
Why?
|
Exanthema | 1 | 2020 | 503 | 0.030 |
Why?
|
Postpartum Period | 1 | 2002 | 1197 | 0.030 |
Why?
|
Microglia | 1 | 2004 | 1376 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3251 | 0.030 |
Why?
|
Neuronal Plasticity | 1 | 2003 | 1448 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2003 | 1388 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1346 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 1942 | 0.030 |
Why?
|
Tanzania | 1 | 2019 | 1407 | 0.030 |
Why?
|
HIV-1 | 1 | 2012 | 6963 | 0.030 |
Why?
|
Occupations | 1 | 2016 | 516 | 0.030 |
Why?
|
Acyclovir | 1 | 2014 | 267 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1648 | 0.030 |
Why?
|
Deglutition Disorders | 1 | 2019 | 640 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1557 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3713 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2121 | 0.030 |
Why?
|
Herpesvirus 2, Human | 1 | 2014 | 191 | 0.030 |
Why?
|
Logistic Models | 2 | 2017 | 13290 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14729 | 0.020 |
Why?
|
Urban Population | 1 | 2019 | 2046 | 0.020 |
Why?
|
Gene Expression | 1 | 2003 | 7601 | 0.020 |
Why?
|
Ritonavir | 1 | 2012 | 332 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 2080 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2003 | 3980 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3814 | 0.020 |
Why?
|
Pain | 1 | 2004 | 5099 | 0.020 |
Why?
|
Chronic Disease | 1 | 2004 | 9384 | 0.020 |
Why?
|
Hypertension | 1 | 2009 | 8616 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2010 | 331 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2763 | 0.020 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2010 | 277 | 0.020 |
Why?
|
Aortography | 1 | 2010 | 422 | 0.020 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2007 | 39 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2003 | 19025 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2012 | 887 | 0.020 |
Why?
|
Angioplasty | 1 | 2010 | 356 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 4585 | 0.020 |
Why?
|
Adenine | 1 | 2012 | 995 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3782 | 0.020 |
Why?
|
Behavior, Animal | 2 | 2004 | 1862 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2008 | 927 | 0.020 |
Why?
|
Computer Simulation | 1 | 1999 | 6283 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 2089 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2019 | 3007 | 0.020 |
Why?
|
Incidental Findings | 1 | 2010 | 698 | 0.020 |
Why?
|
Time Factors | 2 | 2017 | 40220 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6669 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1886 | 0.020 |
Why?
|
Potassium Channels | 1 | 2007 | 538 | 0.010 |
Why?
|
Aging | 1 | 2004 | 8743 | 0.010 |
Why?
|
Endarterectomy, Carotid | 1 | 2010 | 556 | 0.010 |
Why?
|
Developing Countries | 1 | 2017 | 2910 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12077 | 0.010 |
Why?
|
RNA, Viral | 1 | 2012 | 2874 | 0.010 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2003 | 57 | 0.010 |
Why?
|
Child, Preschool | 2 | 2017 | 42669 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8509 | 0.010 |
Why?
|
Prospective Studies | 2 | 2019 | 54924 | 0.010 |
Why?
|
Pain Measurement | 2 | 2004 | 3583 | 0.010 |
Why?
|
Ligation | 1 | 2004 | 446 | 0.010 |
Why?
|
Ion Channels | 1 | 2007 | 1043 | 0.010 |
Why?
|
Axotomy | 1 | 2002 | 71 | 0.010 |
Why?
|
Neural Pathways | 1 | 2013 | 3117 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2683 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4055 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 2004 | 462 | 0.010 |
Why?
|
Electrophysiology | 1 | 2003 | 1266 | 0.010 |
Why?
|
Cell Size | 1 | 2002 | 626 | 0.010 |
Why?
|
Receptor, IGF Type 1 | 1 | 2002 | 384 | 0.010 |
Why?
|
Hyperalgesia | 1 | 2004 | 527 | 0.010 |
Why?
|
Pelvic Pain | 1 | 2002 | 300 | 0.010 |
Why?
|
Cell Count | 1 | 2003 | 1832 | 0.010 |
Why?
|
Sciatic Nerve | 1 | 2002 | 628 | 0.010 |
Why?
|
Child | 2 | 2017 | 80917 | 0.010 |
Why?
|
Stents | 1 | 2010 | 3197 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21538 | 0.010 |
Why?
|
Mice | 1 | 2003 | 82049 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41753 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2002 | 1070 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26379 | 0.010 |
Why?
|
Delivery, Obstetric | 1 | 2002 | 954 | 0.010 |
Why?
|
Infant | 1 | 2016 | 36535 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15453 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16726 | 0.010 |
Why?
|
United States | 1 | 2016 | 73039 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2002 | 11930 | 0.000 |
Why?
|